Global Elastomeric Infusion Pumps Market

Elastomeric Infusion Pumps Market Size, Share, Growth Analysis, By Type(Continuous Rate Elastomeric Pump and Variable Rate Elastomeric Infusion Pump), By Application(Pain Management, Chemotherapy), By End-user(Hospitals, Ambulatory Surgical Centers) - Industry Forecast 2024-2031


Report ID: SQMIG35A2679 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 89 | Figures: 76

Elastomeric Infusion Pumps Market Insights

Elastomeric Infusion Pumps Market size was valued at USD 977.84 million in 2021 and is poised to grow from USD 1067.8 million in 2022 to USD 2159.09 million by 2030, at a CAGR of 9.2 % during the forecast period (2023-2030).

The global elastomeric infusion pump market is experiencing significant growth driven by several key factors. These include the rising number of orthopedic procedures and surgeries, increasing demand for compact disposable ambulatory elastomeric infusion pumps, advancements in technology leading to the introduction of innovative elastomeric infusion pumps, and the growing prevalence of cancer cases and chronic diseases.

The market is experiencing growth primarily due to the increasing prevalence of chronic diseases. For instance, recent data from the International Diabetes Federation Diabetes Atlas Tenth edition in December 2021 revealed that approximately 537 million adults worldwide were diagnosed with diabetes in 2021. This number is projected to reach 643 million by 2030 and 783 million by 2045.

Additionally, according to the World Health Organization (WHO), chronic diseases are expected to cause approximately 41 million deaths each year, accounting for 71% of all global deaths. In low- and middle-income countries, chronic disease-related deaths contribute to 77% of the total.

Furthermore, a study published in May 2022 titled 'Osteomyelitis' indicated that there are around 50,000 reported cases of osteomyelitis annually in the US. The incidence of osteomyelitis is higher in men compared to women and increases with age, which can be attributed to the growing prevalence of comorbid factors such as diabetes mellitus and peripheral vascular disease.

Consequently, the rising burden of chronic diseases among the population is expected to drive the demand for safe medication delivery through intravenous routes. This, in turn, is anticipated to increase the demand for elastomeric infusion pumps, thereby fostering market growth.

US Elastomeric Infusion Pumps Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Elastomeric Infusion Pumps Market size was valued at USD 977.84 million in 2021 and is poised to grow from USD 1067.8 million in 2022 to USD 2159.09 million by 2030, at a CAGR of 9.2 % during the forecast period (2023-2030).

The elastomeric infusion systems market exhibits a moderate level of fragmentation and competitiveness. Market players are actively engaged in strategies such as new product launches, collaborations, and innovations to strengthen their market presence and increase their share. These industry participants continually strive to introduce advanced solutions, forge strategic partnerships, and drive innovation, positioning themselves to capture a larger market share in the dynamic elastomeric infusion systems market. 'Baxter International Inc. (US)', 'B. Braun Melsungen AG (Germany)', 'Avanos Medical, Inc. (US)', 'Nipro Corporation (Japan)', 'Leventon S.A.U (Spain)', 'Fresenius Kabi AG (Germany)', 'Terumo Corporation (Japan)', 'Smiths Medical (UK)', 'CME Medical (United Kingdom)', 'Vygon Group (France)', 'Q Core Medical Ltd. (Israel)', 'Woo Young Medical Co., Ltd. (South Korea)', 'Romsons Group of Industries (India)', 'Halyard Health, Inc. (US)', 'Sooil Development Co., Ltd. (South Korea)', 'Micrel Medical Devices SA (Switzerland)', 'Coopdech (China)', 'Polymedicure Ltd. (India)', 'Shanghai Kindly Medical Instruments Co., Ltd. (China)', 'Coloplast Group (Denmark)'

The rising incidence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is a significant driver for the elastomeric infusion pumps market. These pumps provide a reliable and convenient method of delivering medications for long-term management of chronic conditions.

There was a growing trend towards home healthcare and ambulatory care, driven by factors such as the rising elderly population, preference for cost-effective treatment options, and advancements in medical technology. Elastomeric infusion pumps were being increasingly utilized in homecare settings due to their ease of use, portability, and ability to provide continuous infusion of medications without the need for electronic programming. This trend allowed patients to receive treatment outside of traditional healthcare facilities, promoting patient comfort and reducing the burden on healthcare facilities.

In the elastomeric infusion pumps market, regional insights reveal a dynamic landscape driven by various factors across different regions. North America emerges as the largest market segment, primarily due to the region's advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on technological advancements. The increasing prevalence of chronic diseases, rising demand for pain management solutions, and extensive adoption of elastomeric infusion pumps contribute to the dominance of North America in the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Elastomeric Infusion Pumps Market

Product ID: SQMIG35A2679

$5,300
BUY NOW GET FREE SAMPLE